Your weekly roundup of the latest news from Drug Topics®.
A survey found that only 24.6% of respondents have conducted a skin self-examination in the past 2 months.
Which masks (if any) serve as the best protection against wildfire smoke, and what do experts say about home appliances like air conditioners?
The combination of Lynparza and abiraterone reduced the risk of disease progression or death by 76% vs. abiraterone alone in patients with BRCA-mutated metastatic castration-resistant prostate cancer.
Patients were more likely to require ICU admission.
The median annual cost for new oncology medicines launched in 2022 was $260,000, up from $63,534 10 years ago, an IQVIA report finds.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.